These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11879791)

  • 21. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
    Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
    Butterweck V; Winterhoff H; Herkenham M
    Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin.
    Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE
    Behav Brain Res; 2009 May; 199(2):334-9. PubMed ID: 19136030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
    Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
    J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).
    Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ
    Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of hepatocellular toxicity associated with the components of St. John's Wort extract hypericin and hyperforin in HepG2 and HepaRG cells.
    Abegg VF; Panajatovic MV; Mancuso RV; Allard JA; Duthaler U; Odermatt A; Krähenbühl S; Bouitbir J
    Toxicol Lett; 2024 Mar; 393():1-13. PubMed ID: 38219807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)].
    Güzelcan Y; Scholte WF; Assies J; Becker HE
    Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice.
    Dasgupta A; Hovanetz M; Olsen M; Wells A; Actor JK
    Arch Pathol Lab Med; 2007 Jul; 131(7):1094-8. PubMed ID: 17616997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation.
    Schempp CM; Winghofer B; Müller K; Schulte-Mönting J; Mannel M; Schöpf E; Simon JC
    Phytother Res; 2003 Feb; 17(2):141-6. PubMed ID: 12601676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort).
    Schempp CM; Winghofer B; Langheinrich M; Schöpf E; Simon JC
    Skin Pharmacol Appl Skin Physiol; 1999; 12(5):299-304. PubMed ID: 10461100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
    Wonnemann M; Singer A; Siebert B; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of total hypericins in St. John's wort and herbal medicinal products.
    Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z
    Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway.
    Chang Y; Wang SJ
    Eur J Pharmacol; 2010 May; 634(1-3):53-61. PubMed ID: 20193678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
    Taher MM; Lammering GM; Hershey CM; Valerie KC
    IUBMB Life; 2002 Dec; 54(6):357-64. PubMed ID: 12665247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
    Hostanska K; Reichling J; Bommer S; Weber M; Saller R
    Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
    Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
    Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.